Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Preclinical News

Cambridge team identifies targets specific for squamous lung cancer

Jennie Walters
August 22, 2018 6:35 PM UTC

Researchers at University of Cambridge and colleagues identified an oncogene and epigenetic factors it regulates in lung squamous cell carcinoma (SCC), which could lead to new therapeutic targets for the indication.

The targeted therapy landscape for lung SCC is sparse, and the indication lags behind lung adenocarcinoma in therapeutic targets, even though both represent the most common forms of non-small cell lung cancer (NSCLC)...

Get Unlimited Access
Continue reading with a free trial.
Start a Free TrialLog In
Or Purchase This Article

BCIQ Company Profiles

University of Cambridge